Standout Papers
Citation Impact
Citing Papers
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Effects of an Rb mutation in the mouse
1992 StandoutNature
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
1988 Standout
Delayed graft function in kidney transplantation
2004 Standout
Psoriasis
2009 Standout
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
The p53 proto-oncogene can act as a suppressor of transformation
1989 Standout
Autoimmune Diseases
2001
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
1992 Standout
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Regulatory T Cells
2010
Small‐Molecule Affinity Ligands for Protein Purification: Combined Computational Enrichment and Automated In‐line Screening of an Optically Encoded Library
2010 StandoutNobel
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
1993 Standout
Improving de novo protein binder design with deep learning
2023 StandoutNobel
SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
1999 Standout
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
1990 Standout
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
2015
Structural basis of immunosuppression by the therapeutic antibody daclizumab
2010
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
1988 StandoutNature
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
1990 StandoutNature
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
2006
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Psoriasis: emerging therapeutic strategies
2005
Mutations in the p53 gene occur in diverse human tumour types
1989 StandoutNature
The p53 tumour suppressor gene
1991 StandoutNature
The Natural History of Chronic Allograft Nephropathy
2003 Standout
Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy
2002
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Does subclinical rejection contribute to chronic rejection in renal transplant patients?
1999
Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product
1991 StandoutNobel
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
1992 StandoutNature
The immunologic basis for the treatment of psoriasis with new biologic agents
2002
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
2005
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Psoriasis
2003
Chronic Lung Allograft Rejection: Mechanisms and Therapy
2009
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATION
2001
Infection in Solid-Organ Transplant Recipients
2007 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci
2008
The cancer genome
2009 StandoutNature
Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study
2007
Therapeutic monoclonal antibodies
2000
p53 Mutations in Human Cancers
1991 StandoutScience
An immunoaffinity purification procedure for sv40 large t antigen
1985
Fragments of the simian virus 40 transforming gene facilitate transformation of rat embryo cells.
1982
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes Implications for Immunotherapy
2001
Fission yeast Schizosaccharomyces pombe correctly excises a mammalian RNA transcript intervening sequence
1985 StandoutNatureNobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Strategien zur Modulation von Protein‐Protein‐Wechselwirkungen mit synthetischen Substanzen
2005
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation
2005
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Transforming activity of human tumor DNAs.
1981
Tumor antigen(s) in cells productively infected by wild-type polyoma virus and mutant NG-18
1978
The SV40 a gene product is required for the production of a 54,000 MW cellular tumor antigen
1979
G 1 Events and Regulation of Cell Proliferation
1989 StandoutScience
Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein
1978 StandoutNobel
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
1979
Synthesis of labile, serum-dependent protein in early G 1 controls animal cell growth
1979
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
1990 StandoutScience
Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes
2001
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
1989 StandoutScience
The Yin and Yang of regulatory T cells in infectious diseases and avenues to target them
2017
Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol
2001 Standout
Works of Susan Light being referenced
Daclizumab: outcome of phase III trials and mechanism of action
1998
PHASE I TRIAL OF HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM LIVING DONORS1
2000
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Pharmacokinetics, pharmacodynamics, and immunodynamics of daclizumab in a two-dose regimen in liver transplantation1
2002
Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis
2000
A PHASE I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL TRANSPLANTATION1
1997
Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation
2003
Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti‐tac
1998
REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1
1999
A cloned polyoma DNA fragment representing the 5' half of the early gene region is oncogenic
1980
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
2000
Purification of simian virus 40 tumor antigen from a line of simian virus 40-transformed human cells.
1977
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
2000
Measurements of the molecular size of the simian virus 40 large T antigen
1978